| Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris, ... JAMA Network Open 5 (9), e2231982-e2231982, 2022 | 79 | 2022 |
| Effects of heterozygous variants in the leptin-melanocortin pathway on Roux-en-Y gastric bypass outcomes: a 15-Year case–control study A Campos, L Cifuentes, A Hashem, B Busebee, MD Hurtado-Andrade, ... Obesity surgery 32 (8), 2632-2640, 2022 | 23 | 2022 |
| Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study L Cifuentes, W Ghusn, F Feris, A Campos, D Sacoto, A De la Rosa, ... EClinicalMedicine 58, 2023 | 21 | 2023 |
| Association between Food Intake and Gastrointestinal Symptoms in Patients with Obesity L Cifuentes, A Campos, D Sacoto, A De La Rosa, F Feris, G Calderon, ... | 5* | |
| Cardiovascular risk and diseases in patients with and without leptin-melanocortin pathway variants L Cifuentes, A Campos, D Sacoto, W Ghusn, A De la Rosa, F Feris, ... Mayo Clinic Proceedings 98 (4), 533-540, 2023 | 4 | 2023 |
| A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center A De la Rosa, W Ghusn, D Sacoto, A Campos, L Cifuentes, F Feris, ... Obesity Pillars 4, 100046, 2022 | 4 | 2022 |
| Mucosal and hormonal adaptations after Roux-en-Y gastric bypass F Feris, A McRae, TA Kellogg, T McKenzie, O Ghanem, A Acosta Surgery for Obesity and Related Diseases 19 (1), 37-49, 2023 | 3 | 2023 |
| The effect of heterozygous gene variants of the leptin-melanocortin pathway on weight loss following sleeve gastrectomy F Feris, W Ghusn, A Campos, L Cifuentes, A De la Rosa, D Sacoto, ... Obesity Surgery 33 (7), 2246-2249, 2023 | 1 | 2023 |
| 983 SHORT-AND LONG-TERM GUT MUCOSAL ADAPTATIONS TO DIETINDUCED WEIGHT LOSS COMPARED TO ROUX-EN-Y-INDUCED WEIGHT LOSS IN PATIENTS WITH OBESITY A Mcrae, D Anazco, F Feris, AL Ticho, W Ghusn, NN Mangena, S Fansa, ... Gastroenterology 166 (5), S-237-S-238, 2024 | | 2024 |
| The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes W Ghusn, S Fansa, D Anazco, E Tama, L Cifuentes, K Gala, ... Diabetes, Obesity and Metabolism, 2024 | | 2024 |
| Type 2 Diabetes Remission in Patients with Leptin-Melanocortin Pathway Variants after Gastric Bypass D Anazco, W Ghusn, S Fansa, E Tama, A Campos-Martinez, L Cifuentes, ... OBESITY 31, 29-30, 2023 | | 2023 |
| The Individualized Metabolic Surgery Score Predicts Weight Loss in Patients with T2DM on Semaglutide W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ... OBESITY 31, 82-83, 2023 | | 2023 |
| S1485 Semaglutide Outcomes in Non-Alcoholic Fatty Liver Disease: A Multi-Centered Real-World Study W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, L Cifuentes, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1648 Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study W Ghusn, D Anazco, S Fansa, E Tama, A De La Rosa, B Nicolalde, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| S1632 Effect of Changes in Gastric Emptying and Low-Calorie Phenotype Tailored Diet on Weight Loss: Results From a 12-week Clinical Trial L Cifuentes, W Ghusn, A Campos, F Feris, D Sacoto, A De la Rosa, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| Tu1920 SATIETY GLP-1 AND PYY HORMONES PLASMA CONCENTRATION IS NOT ASSOCIATED WITH M-RNA GUT MUCOSAL EXPRESSION IN DIET INDUCED OBESITY MICE NN Mangena, A Mcrae, F Feris, A De la Rosa, A Acosta Gastroenterology 164 (6), S-1162, 2023 | | 2023 |
| Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY W Ghusn, S Fansa, B Nicolalde, A De la Rosa, L Cifuentes, D Sacoto, ... Gastroenterology 164 (6), S-937, 2023 | | 2023 |
| 327 REGULATOR OF G-PROTEIN SIGNALING AS AN ENTEROENDOCRINE-SPECIFIC TARGET FOR OBESITY TREATMENT: ALTERED RGS9 IN ENTEROENDOCRINE CELLS IMPAIRS POSTPRANDIAL GLP-1 RESPONSE AND … A Mcrae, NN Mangena, F Feris, A De la Rosa, A Acosta Gastroenterology 164 (6), S-56-S-57, 2023 | | 2023 |
| SOARD Category 1 CME Credit Featured Articles, Volume 19, January 2023 Z Cai, Q Zhang, Y Jiang, J Zhang, W Liu, F Feris, A McRae, TA Kellogg, ... Surg Obes Relat Dis 19, 37-49, 2023 | | 2023 |
| A Phenotype Tailored Lifestyle Intervention for Weight Loss: Results From a 12-Week Clinical Trial L Cifuentes, W Ghusn, F Feris, A Campos, D Sacoto, A De la Rosa, ... Obesity 30, 41-42, 2022 | | 2022 |
Alan De la RosaInternal Medicine ll TTUHSC El Paso ll Mayo ClinicVerified email at ttuhsc.edu
